Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases.
about
Recent Advances in Chemotherapy and Surgery for Colorectal Liver MetastasesThe role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis.Predictors of Safety and Efficacy of 2-Stage Hepatectomy for Bilateral Colorectal Liver Metastases.Biomarker in Colorectal Cancer.Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastasesPre-hepatectomy carcinoembryonic antigen (CEA) levels among patients undergoing resection of colorectal liver metastases: do CEA levels still have prognostic implications?Important molecular genetic markers of colorectal cancer.Remnant Liver Ischemia as a Prognostic Factor for Cancer-Specific Survival After Resection of Colorectal Liver Metastases.Oligometastatic Disease in Colorectal Cancer - How to Proceed?Management of patients with colorectal liver metastasis in eleven questions and answers.Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location.Patient selection for the surgical treatment of resectable colorectal liver metastases.The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis.Tumor Biology Rather Than Surgical Technique Dictates Prognosis in Colorectal Cancer Liver Metastases.Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.KRAS Mutation Status Predicts Site-Specific Recurrence and Survival After Resection of Colorectal Liver Metastases Irrespective of Location of the Primary Lesion.Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status.Validation of clinical risk scores for laparoscopic liver resections of colorectal liver metastases: A 10-year observed follow-up study.Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations.RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver MetastasesCan molecular biomarkers replace a clinical risk score for resectable colorectal liver metastasis?Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases.SSAT State-of-the-Art Conference: New Frontiers in Liver Surgery.Risk Factors for Unresectable Recurrence After Up-Front Surgery for Colorectal Liver Metastasis.The RAS mutation status predicts survival in patients undergoing hepatic resection for colorectal liver metastases: The results from a genetic analysis of all-RAS.Colorectal cancer liver metastases - a population-based study on incidence, management and survival.Surgery: KRAS mutations and hepatic recurrence after treatment of colorectal liver metastases.RAS Mutation Is Associated with Decreased Survival in Patients Undergoing Repeat Hepatectomy for Colorectal Liver Metastases.Assessment of Overall Survival Benefits in Patients Undergoing Complete Hepatectomy for Synchronous Colorectal Cancer With Liver and Lung Metastases.Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases.Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer
P2860
Q28067408-595EC783-0B65-4A65-A584-A98E0076E6B8Q35988684-6B70995B-8436-40AB-847C-3B90305C9460Q37047788-7A085553-CF0C-46A0-8B2A-868FA23FA272Q37114675-92F34B0D-E58A-45DB-969B-11E0491C1BB5Q37352557-0F8768B2-1324-41E6-A136-656E5D4ABAA3Q37484579-BA5B2968-08F3-4B6C-AB40-C17E300CBABAQ37619856-A86A89BE-6B28-4CD2-AD9C-4110BBA5B0EAQ38602133-B1F61811-A06E-4918-96A2-41C1F3F71EEDQ38726780-E4A4B7D0-69DD-464A-A012-BD1B67D19A28Q38811107-0B954D41-D00B-4557-9BFA-EC71318D7BF9Q38847613-CC19E2DE-DD53-431C-A43D-095F821C4EC5Q38990110-598D2984-CC6F-4387-A635-32693F226493Q39238657-5D1CB336-6300-4A3D-A144-BB6A8EA95B17Q39626850-714E006F-E754-4303-A9C7-CB84CB1B6F90Q39722702-A5930F24-3827-4F19-808D-F03B61C8998BQ40087648-EDCC0803-DDA6-49EE-B13B-5EFF23D62256Q40317208-A0001E35-0141-47D2-8291-DE8B8A028F94Q40510578-8226E20C-EE58-43A3-B50C-827D62A2B919Q40674654-80482728-25D8-4C20-88E1-AF718E0382C7Q41129943-96DED819-EF56-4497-A82F-13B41452F850Q42316697-ACF690BD-55A0-41F0-A622-B90801011F18Q42371613-E9B0BA03-4297-4D0E-B0EC-1A7DE9DCBA87Q45296595-8B415D2D-1569-43F3-B0F6-6E721FD99C1DQ47277006-4D005E52-B518-4DA6-B5E4-C9549EE0A116Q48197461-673BB036-D772-4EEE-881F-199DE8D47FE3Q48241834-955C79C3-CF7F-406B-A6D9-68C9292AD738Q49994965-6A9CBAF9-B62F-4405-8136-253BC008808EQ52982174-D054E442-6C9A-498A-A39F-C40EC5FF9C3AQ55004040-56C79026-BDAA-4F26-8546-129E5BC06AFEQ55125985-699601FD-45D5-4F69-AE06-AA3F07BCBA7AQ56969146-B504EC9E-FF7A-4FC8-875A-6AB61CFD97EF
P2860
Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Meta-analysis of KRAS mutation ...... f colorectal liver metastases.
@ast
Meta-analysis of KRAS mutation ...... f colorectal liver metastases.
@en
type
label
Meta-analysis of KRAS mutation ...... f colorectal liver metastases.
@ast
Meta-analysis of KRAS mutation ...... f colorectal liver metastases.
@en
prefLabel
Meta-analysis of KRAS mutation ...... f colorectal liver metastases.
@ast
Meta-analysis of KRAS mutation ...... f colorectal liver metastases.
@en
P2093
P2860
P356
P1476
Meta-analysis of KRAS mutation ...... f colorectal liver metastases.
@en
P2093
P2860
P304
P356
10.1002/BJS.9870
P407
P50
P577
2015-07-21T00:00:00Z